Expression Pattern of the PRDX2, RAB1A, RAB1B, RAB5A and RAB25 Genes in Normal and Cancer Cervical Tissues
Total Page:16
File Type:pdf, Size:1020Kb
INTERNATIONAL JOURNAL OF ONCOLOGY 46: 107-112, 2015 Expression pattern of the PRDX2, RAB1A, RAB1B, RAB5A and RAB25 genes in normal and cancer cervical tissues ANDREJ NIKOSHKOV1, KRISTINA BROLIDEN2, SANAZ ATTARHA1,3, VITALI SVIATOHA3, ANN-CATHRIN HELLSTRÖM4, MIRIAM MINTS1 and SONIA ANDERSSON1 1Department of Women's and Children's Health, Division of Obstetrics and Gynecology, Karolinska Institute, Karolinska University Hospital Solna, 171 76 Stockholm; 2Department of Medicine Solna, Unit of Infectious Diseases, Center for Molecular Medicine, Karolinska Institute, Karolinska University Hospital, 171 76 Stockholm; 3Department of Oncology-Pathology, Karolinska Institute, 171 76 Stockholm; 4Department of Gynecological Oncology, Radiumhemmet, Karolinska University Hospital, 171 76 Stockholm, Sweden Received July 11, 2014; Accepted August 28, 2014 DOI: 10.3892/ijo.2014.2724 Abstract. Cervical cancer is the second most prevalent RAB1B transcript occurs in normal cervical tissue and in malignancy among women worldwide, and additional preinvasive cervical lesions; not in invasive cervical tumors. objective diagnostic markers for this disease are needed. Given the link between cancer development and alternative Introduction splicing, we aimed to analyze the splicing patterns of the PRDX2, RAB1A, RAB1B, RAB5A and RAB25 genes, which Alternative splicing is a process in which either different are associated with different cancers, in normal cervical combinations of exons or parts of exons are employed to tissue, preinvasive cervical lesions and invasive cervical generate new transcripts through the use of alternative-splicing tumors, to identify new objective diagnostic markers. Biopsies sites. More than 90% of human intron-containing genes of normal cervical tissue, preinvasive cervical lesions and undergo alternative splicing, which allows a single transcript invasive cervical tumors, were subjected to rapid amplification to encode a number of RNAs that produce various protein of cDNA 3' ends (3' RACE) RT‑PCR. Resulting PCR products isoforms with different functions (1). A complex array of were analyzed on agarose gels, gel‑purified and sequenced. cis elements (the splicing code) embedded in pre-mRNAs, Normal cervical tissue, preinvasive cervical lesions and together with trans-acting factors that bind to these elements, invasive cervical tumors contained one PCR product are required for the precise process of pre‑mRNA splicing and corresponding to full-length PRDX2, RAB5A and RAB25 its regulation. The splicing code for the majority of introns transcripts. All tissues contained two RAB1A‑specific PCR comprises short sequences that include the 5' and 3' splice products corresponding to the full-length transcript and one sites located at both intron-exon junctions and at the branch new alternatively spliced RAB1A transcript. Invasive cervical point. These sequences are recognized by the spliceosome, tumors contained one PCR product corresponding to the which is composed of five small nuclear ribonucleoproteins full-length RAB1B transcript, while all normal cervical tissue and ~150 proteins. In addition to the core cis elements in and preinvasive cervical lesions contained both the full-length pre‑mRNAs, other sequences in introns and exons, which are RAB1B transcript and three new alternatively spliced RAB1B recognized by cellular trans-acting factors, are also critical to transcripts. Alternative splicing of the RAB1A transcript the determination of splicing outcomes (2). occurs in all cervical tissues, while alternative splicing of the In the last few years, a link has emerged between cancer development and deregulation of alternative splicing (3). Approximately 10% of inherited or somatic mutations are localized within sequences coding canonical splice sites (4), and these mutations have been implicated in cancer susceptibility and tumor progression. One such example is Correspondence to: Professor Sonia Andersson, Department of the tumor suppressor gene p53, the most commonly mutated Women's and Children's Health, Division of Obstetrics and Gynecology, Karolinska Institute, Elevhemmet H2:00, Karolinska gene in human cancers. Isoforms of the p53 gene are created University Hospital Solna, 171 76 Stockholm, Sweden through alternative splicing, and their tumor suppressor E‑mail: [email protected] functions differ (5). ‘Silent’ mutations in the p53 gene have been predicted to affect splicing by creating splice sites in the Key words: cervical cancer, alternative splicing, peroxiredoxin 2, middle of an exon (6). Recently, it has been reported that an RAB1B, member RAS oncogene family attenuated form of familiar adenomatous polyposis is caused by the insertion of a single T between the second and third nucleotide of intron 4 of the APC gene, which leads to the 108 NIKOSHKOV et al: ExpREssION PATTERN OF DIAGNOSTIC BIOMARKERS IN CERVICAL CANCER skipping of exon 4, and a predicted expression of a truncated Materials and methods protein (7). Another good example of altered splicing in tumorigenesis occurs in the tumor suppressor gene BRCA1. Between 2012 and 2013, 28 women were enrolled in the present Mutations in the BRCA1 gene are well-known markers of study: 10 healthy female volunteers (c1-c10), eight women susceptibility to ovarian and breast cancer, the latter being with preinvasive cervical lesions (p1-p8), and 10 women with the most common malignancy in women. One such mutation invasive cervical tumors (i1-i10). Each woman underwent in the BRCA1 gene is an inherited nonsense mutation within a pelvic examination followed by biopsy collection at one exon 18 that disrupts the exonic splicing enhancer of the gene, of two departments in Stockholm, Sweden: the Division of provoking exon skipping (8). Obstetrics and Gynecology, Karolinska University Hospital, or Alterations in signaling pathways cause changes in the the Department of Gynecological Oncology, Radiumhemmet, abundance, localization and activity of splicing regulators, Karolinska University Hospital. All biopsies were immediately which in turn can cause a general deregulation of splicing, and flash frozen in liquid nitrogen and then stored at ‑80˚C. result in the occurrence of cancer‑specific transcripts that are Biopsies were grouped according to morphological diagnosis. associated with tumorigenesis. Recent progress in molecular Ethical approval was obtained from the Regional Ethics and cell biology has indicated that altered splicing profiles of Review Board in Stockholm, and an informed consent form critical genes may impact all aspects of cancer cell biology (9), was signed by all participants prior to inclusion. resulting in the inactivation of tumor suppressor genes (6), or the gain of function of proteins implicated in cancer suscepti- RNA preparations, cDNA synthesis. Approximately 30 mg of bility and tumor progression (9,10). biopsy tissue was homogenized in microtubes with disposable Human papillomavirus (HPV) infection is a necessary, but pestles driven by cordless motor (VWR, Radnor, PA, USA). not sufficient factor in the development of cervical neoplasia, Total RNA from homogenized biopsies was isolated using and persistent infection with high-risk HPV types, especially RNeasy kits (Qiagen, Hilden, Germany) according to the HPV16, is a significant risk factor in the development of manufacturer's instructions. Total RNA (200 ng) was reverse precancerous lesions and squamous cell carcinoma (11‑14). transcribed with SuperScript Ⅲ, and amplified with Platinum HPV‑16, ‑18, ‑45, ‑31 and ‑33 are the most frequently identified Taq DNA polymerase in 30 µl of a one‑step RT‑PCR system high‑risk HPV types in high‑grade squamous intraepithelial (Invitrogen, Carlsbad, CA, USA) according to the manufacturer's lesions and squamous cell carcinoma (15), though HPV16 instructions. The reverse transcription reaction was performed predominates (16). An association has also been suggested at 50˚C to destroy mRNA secondary structures. between high viral load and the persistence of HPV infection (17). Promising HPV‑related markers of the risk of 3' RACE RT‑PCR. To detect multiple transcripts of the PRDX2, progression to cervical cancer include the integration status of RAB1A, RAB1B, RAB5A and RAB25 genes, we applied the high-risk HPV DNA in precancerous cervical lesions (18). HPV rapid amplification of cDNA 3' ends (3' RACE) RT‑PCR DNA integration into the host cell genome usually disrupts the approach, which uses the natural polyA tail that exists at the E1 and E2 open reading frames, but leaves those of E6 and 3' end of most eukaryotic mRNAs for priming during reverse E7 intact (19,20). The deletion of the E2 open reading frame transcription. cDNAs were generated using an oligo-dT‑adaptor due to HPV DNA integration leads to the disruption of E2 GACTCGAGTCGACATCGATAG(T)19 primer that comple- protein expression, and the upregulation of E6 and E7 protein ments the polyA stretch and adds a special adaptor sequence to transcription (21); continuous production of the oncogenic E6 the 5' end of each cDNA. Further amplification of cDNAs in and E7 proteins contribute to malignant progression. the one-step RT‑PCR reaction was performed using the reverse It was recently demonstrated that level of the splicing TAILR, GACTCGAGTCGACATCGATAG primer targeting activator ASF/SF2 (also known as arginine/serine-rich splicing the adaptor sequence, and forward PRDX164F, CAGTC factor 1) is modulated in the presence of HPV infection (22), ATGGCCTCCGGTAA; RAB1A397F, CTGCAGTGACAT as is the splicing